1. Home
  2. RCEL vs CCCC Comparison

RCEL vs CCCC Comparison

Compare RCEL & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • CCCC
  • Stock Information
  • Founded
  • RCEL N/A
  • CCCC 2015
  • Country
  • RCEL United States
  • CCCC United States
  • Employees
  • RCEL N/A
  • CCCC N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • RCEL Health Care
  • CCCC Health Care
  • Exchange
  • RCEL Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • RCEL N/A
  • CCCC 244.9M
  • IPO Year
  • RCEL N/A
  • CCCC 2020
  • Fundamental
  • Price
  • RCEL $8.14
  • CCCC $1.60
  • Analyst Decision
  • RCEL Buy
  • CCCC Buy
  • Analyst Count
  • RCEL 5
  • CCCC 4
  • Target Price
  • RCEL $17.25
  • CCCC $12.50
  • AVG Volume (30 Days)
  • RCEL 194.6K
  • CCCC 813.4K
  • Earning Date
  • RCEL 05-12-2025
  • CCCC 05-07-2025
  • Dividend Yield
  • RCEL N/A
  • CCCC N/A
  • EPS Growth
  • RCEL N/A
  • CCCC N/A
  • EPS
  • RCEL N/A
  • CCCC N/A
  • Revenue
  • RCEL $64,251,000.00
  • CCCC $35,584,000.00
  • Revenue This Year
  • RCEL $61.91
  • CCCC N/A
  • Revenue Next Year
  • RCEL $31.36
  • CCCC $36.32
  • P/E Ratio
  • RCEL N/A
  • CCCC N/A
  • Revenue Growth
  • RCEL 28.14
  • CCCC 71.44
  • 52 Week Low
  • RCEL $7.51
  • CCCC $1.59
  • 52 Week High
  • RCEL $15.98
  • CCCC $8.29
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 39.91
  • CCCC 23.30
  • Support Level
  • RCEL $8.91
  • CCCC $1.79
  • Resistance Level
  • RCEL $9.41
  • CCCC $2.28
  • Average True Range (ATR)
  • RCEL 0.49
  • CCCC 0.15
  • MACD
  • RCEL -0.02
  • CCCC -0.01
  • Stochastic Oscillator
  • RCEL 0.60
  • CCCC 2.16

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Share on Social Networks: